{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:23:26Z","timestamp":1791829406905,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.urology.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T06:45:10Z","timestamp":1721198710000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States"],"prefix":"10.1016","volume":"191","author":[{"given":"Ekene A.","family":"Enemchukwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shada","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodan","family":"Mohamud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyuan A.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T.","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Charles D.","family":"Scales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2024.07.006_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"Haylen","year":"2010","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.urology.2024.07.006_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","article-title":"The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study","volume":"101","author":"Coyne","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.07.006_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urology.2017.03.058","article-title":"Overactive bladder is strongly associated with frailty in older individuals","volume":"106","author":"Suskind","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.07.006_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/gerona\/62.7.731","article-title":"Frailty: an emerging research and clinical paradigm--issues and controversies","volume":"62","author":"Bergman","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.urology.2024.07.006_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066269","article-title":"Association between frailty, chronic conditions and socioeconomic status in community-dwelling older adults attending primary care: a cross-sectional study using practice-based research network data","volume":"13","author":"Mangin","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.urology.2024.07.006_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.urology.2024.07.006_bib7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.urology.2024.07.006_bib8","doi-asserted-by":"crossref","unstructured":"Dmochowski R.R., Thai S., Iglay K., et al. Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn. 2021;40:28-37. 10.1002\/nau.24536.","DOI":"10.1002\/nau.24536"},{"key":"10.1016\/j.urology.2024.07.006_bib9","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/nau.25037","article-title":"SUFU white paper on overactive bladder anticholinergic medications and dementia risk","volume":"41","author":"Zillioux","year":"2022","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2024.07.006_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/bju.15040","article-title":"Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study","volume":"126","author":"Welk","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.07.006_bib11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU Guideline Amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.07.006_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/SPV.0000000000001008","article-title":"Clinical Consensus Statement: association of anticholinergic medication use and cognition in women with overactive bladder","volume":"27","year":"2021","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.urology.2024.07.006_bib13","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/SPV.0000000000001145","article-title":"A physician-led communication initiative to inform OAB patients of dementia risk associated with anticholinergic medications","volume":"28","author":"Millimet","year":"2022","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.urology.2024.07.006_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/13696998.2017.1294595","article-title":"Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada","volume":"20","author":"Hakimi","year":"2017","journal-title":"J Med Econ"},{"key":"10.1016\/j.urology.2024.07.006_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.urology.2019.02.024","article-title":"The association between race and frailty in older adults presenting to a nononcologic urology practice","volume":"127","author":"Washington","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.07.006_bib16","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00192-021-04909-5","article-title":"A systematic review of neurocognitive dysfunction with overactive bladder medications","volume":"32","author":"Duong","year":"2021","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.urology.2024.07.006_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12955-018-0892-0","article-title":"Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)","volume":"16","author":"Herschorn","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.urology.2024.07.006_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12877-020-1474-7","article-title":"Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)","volume":"20","author":"Griebling","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.urology.2024.07.006_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026391","article-title":"Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study","volume":"9","author":"Szabo","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.urology.2024.07.006_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.15074","article-title":"Inequities in filled overactive bladder medication prescriptions in the US","volume":"6","author":"Luchristt","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urology.2024.07.006_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.urology.2020.04.109","article-title":"Racial and socioeconomic factors influence utilization of advanced therapies in commercially insured OAB patients: an analysis of over 800,000 OAB patients","volume":"142","author":"Syan","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.07.006_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2023.09.020","article-title":"Analyzing access and costs of oral medications for overactive bladder: uncovering disparities","volume":"183","author":"Shapiro","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.07.006_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/nau.24827","article-title":"The risk of delirium and falls or fractures with the use of overactive bladder anticholinergic medications","volume":"41","author":"Welk","year":"2022","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2024.07.006_bib24","first-page":"1","article-title":"Compared to Canadians, U.S. physicians spend nearly four times as much money interacting with payers","volume":"14","author":"Zimmerman","year":"2011","journal-title":"Find Brief"},{"key":"10.1016\/j.urology.2024.07.006_bib25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1377\/hlthaff.2010.0893","article-title":"US physician practices versus Canadians: spending nearly four times as much money interacting with payers","volume":"30","author":"Morra","year":"2011","journal-title":"Health Aff"},{"key":"10.1016\/j.urology.2024.07.006_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/M16-2697","article-title":"Putting patients first by reducing administrative tasks in health care: a position paper of the American College of Physicians","volume":"166","author":"Erickson","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524005600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524005600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:12:37Z","timestamp":1730463157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429524005600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":26,"alternative-id":["S0090429524005600"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2024.07.006","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}